Global investment giant Ardian has reinvested in Italian pharmaceutical commercialisation business Neopharmed. The post Ardian reinvests in Italian pharma business Neopharmed, NB Renaissance joins as investor first appeared on AltAssets Private Equity News.
European mid-market buyout investor Stanley Capital Partners has scored a big exit success with the sale of Noden Pharma after just two years in its portfolio. The post Stanley Capital scores 151% IRR on its
UK mid-market buyout house Graphite Capital has exited scientific animation producer Random42 in a trade deal to The Lockwood Group. The post Graphite Capital exits scientific animation producer Random42 after five years first appeared on AltAssets Private
Private equity giant Blackstone is said to be nearing a deal to buy pharmaceuticals and regulatory consulting business Advarra from Genstar Capital at $5bn valuation. The post Blackstone near deal to buy Advarra from Genstar
European private equity house Triton has agreed a £1.2bn take private deal with UK pharmaceutical firm Clinigen. The post Triton to take UK pharmaceutical firm Clinigen private in a £1.2bn deal first appeared on AltAssets
Global buyout giant Blackstone has agreed to acquire Australian clinical trials provider Nucleus Network. The post Blackstone to acquire Australian clinical trials provider Nucleus Network eyeing increasing demand from offshore biotech companies first appeared on
HIG has bought into UK generic and branded pharmaceutical supplier Aspire Pharma. The post HIG buys into niche pharmaceutical products supplier Aspire Pharma first appeared on AltAssets Private Equity News.
Bain Capital has sold its stake in Korean cosmetic pharmaceutical company Hugel to a consortium led by CBC Group to give the business a $2.5bn valuation. The post Bain Capital seals $2.5bn Hugel sale to
A consortium led by private equity house CBC Group is said to be in advanced talks with Bain’s Capital to acquire its majority stake in Korean cosmetic pharmaceutical company Hugel Inc. The post CBC-led group
The already intensely heated pharmaceutical and medical investment market has grown even more competitive over the past year thanks to rising interest amid the Covid-19 pandemic. Consolidation within the market has also seen the bar
Private equity major New Mountain Capital has bought into Wind Point Partners' specialist chemicals provider Ascensus Specialties after double-digit organic growth. Former majority shareholder Wind Point will reinvest in the company through a special purpose
French pharmaceutical giant Sanofi has made a €50m investment in biotech and biopharma venture investment house Jeito Capital.
Asian private equity investor PAG has reportedly teamed with CX Partners and Samara Capital to buy a controlling stake in Indian drug maker Anjan Drug.
Advanced therapies-focused venture capital firm 4BIO Capital has picked up a strategic investment in its newest fund from specialist pharma and biotech business Kyowa Kirin.
